Vanguard Group
LSTA icon

Vanguard Group’s Lisata Therapeutics LSTA Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$732K Hold
254,182
﹤0.01% 3834
2025
Q1
$597K Buy
254,182
+67,816
+36% +$159K ﹤0.01% 3839
2024
Q4
$555K Hold
186,366
﹤0.01% 3923
2024
Q3
$559K Buy
186,366
+2,033
+1% +$6.1K ﹤0.01% 3945
2024
Q2
$640K Buy
184,333
+2,641
+1% +$9.16K ﹤0.01% 3925
2024
Q1
$567K Buy
181,692
+4,727
+3% +$14.7K ﹤0.01% 3984
2023
Q4
$483K Buy
176,965
+826
+0.5% +$2.26K ﹤0.01% 4036
2023
Q3
$377K Hold
176,139
﹤0.01% 4135
2023
Q2
$652K Hold
176,139
﹤0.01% 4036
2023
Q1
$572K Hold
176,139
﹤0.01% 4092
2022
Q4
$446K Sell
176,139
-166
-0.1% -$420 ﹤0.01% 4125
2022
Q3
$817K Sell
176,305
-2,468,303
-93% -$11.4M ﹤0.01% 4063
2022
Q2
$1.4M Sell
2,644,608
-47,737
-2% -$25.3K ﹤0.01% 3968
2022
Q1
$1.94M Hold
2,692,345
﹤0.01% 3971
2021
Q4
$2.27M Sell
2,692,345
-3,570
-0.1% -$3.01K ﹤0.01% 3992
2021
Q3
$3.29M Sell
2,695,915
-2,120
-0.1% -$2.59K ﹤0.01% 3881
2021
Q2
$4.34M Sell
2,698,035
-108,732
-4% -$175K ﹤0.01% 3666
2021
Q1
$5.42M Buy
2,806,767
+2,464,159
+719% +$4.76M ﹤0.01% 3487
2020
Q4
$490K Buy
342,608
+17,000
+5% +$24.3K ﹤0.01% 3954
2020
Q3
$586K Buy
325,608
+71,613
+28% +$129K ﹤0.01% 3783
2020
Q2
$452K Buy
253,995
+10,230
+4% +$18.2K ﹤0.01% 3792
2020
Q1
$439K Sell
243,765
-550
-0.2% -$991 ﹤0.01% 3696
2019
Q4
$613K Hold
244,315
﹤0.01% 3758
2019
Q3
$618K Buy
244,315
+36,342
+17% +$91.9K ﹤0.01% 3768
2019
Q2
$474K Buy
207,973
+14,740
+8% +$33.6K ﹤0.01% 3838
2019
Q1
$700K Buy
193,233
+5,600
+3% +$20.3K ﹤0.01% 3712
2018
Q4
$668K Sell
187,633
-14,935
-7% -$53.2K ﹤0.01% 3669
2018
Q3
$1.2M Buy
202,568
+5,700
+3% +$33.7K ﹤0.01% 3682
2018
Q2
$1.27M Buy
196,868
+9,408
+5% +$60.9K ﹤0.01% 3627
2018
Q1
$1.09M Buy
187,460
+85,398
+84% +$498K ﹤0.01% 3629
2017
Q4
$358K Sell
102,062
-44,136
-30% -$155K ﹤0.01% 3820
2017
Q3
$524K Sell
146,198
-9,182
-6% -$32.9K ﹤0.01% 3738
2017
Q2
$723K Buy
155,380
+4,163
+3% +$19.4K ﹤0.01% 3650
2017
Q1
$761K Buy
151,217
+42,644
+39% +$215K ﹤0.01% 3650
2016
Q4
$307K Sell
108,573
-17,234
-14% -$48.7K ﹤0.01% 3820
2016
Q3
$583K Sell
125,807
-1,200,040
-91% -$5.56M ﹤0.01% 3724
2016
Q2
$783K Buy
1,325,847
+20,424
+2% +$12.1K ﹤0.01% 3675
2016
Q1
$979K Buy
1,305,423
+51,509
+4% +$38.6K ﹤0.01% 3606
2015
Q4
$1.35M Buy
1,253,914
+46,444
+4% +$50.2K ﹤0.01% 3531
2015
Q3
$1.8M Buy
1,207,470
+95,081
+9% +$142K ﹤0.01% 3421
2015
Q2
$2.08M Buy
1,112,389
+217,186
+24% +$406K ﹤0.01% 3404
2015
Q1
$2.27M Buy
895,203
+61,747
+7% +$157K ﹤0.01% 3350
2014
Q4
$3.14M Buy
833,456
+104,480
+14% +$394K ﹤0.01% 3108
2014
Q3
$4.03M Buy
728,976
+101,818
+16% +$563K ﹤0.01% 2947
2014
Q2
$4.09M Buy
627,158
+49,970
+9% +$326K ﹤0.01% 2952
2014
Q1
$4.07M Buy
577,188
+89,060
+18% +$628K ﹤0.01% 2932
2013
Q4
$3.33M Buy
488,128
+149,064
+44% +$1.02M ﹤0.01% 2984
2013
Q3
$2.9M Sell
339,064
-3,003,591
-90% -$25.7M ﹤0.01% 2994
2013
Q2
$1.86M Buy
+3,342,655
New +$1.86M ﹤0.01% 3089